Zobrazeno 1 - 10
of 38
pro vyhledávání: '"S. J. Basta"'
Publikováno v:
Urology Practice. 6:289-293
Introduction:We compared the perioperative efficiency and outcomes of ureteroscopy performed at an ambulatory surgery center versus a tertiary care academic medical center.Methods:With inst...
Autor:
S. J. Basta
Publikováno v:
Journal of Clinical Anesthesia. 4:153-163
Mivacurium chloride (Mivacron) is a new benzylisoquinolinium choline-like diester neuromuscular blocking drug with an onset of action at equipotent doses that is comparable to atracurium and vecuronium but slower than succinylcholine. Its clinical du
Autor:
S J, Basta
Publikováno v:
Journal of clinical anesthesia. 4(2)
Mivacurium chloride (Mivacron) is a new benzylisoquinolinium choline-like diester neuromuscular blocking drug with an onset of action at equipotent doses that is comparable to atracurium and vecuronium but slower than succinylcholine. Its clinical du
Publikováno v:
Anesthesiology. 77:A404
Autor:
Hassan H. Ali, Ann F. Schwartz, David L. Dresner, William A. Wargin, Karen A. Brady, P. B. Embree, Allen A. Lai, John J. Savarese, S. J. Basta
Publikováno v:
Anesthesia & Analgesia. 71:498
Preliminary disposition studies of the investigational, long-acting muscle relaxant doxacurium chloride (Nuromax) have demonstrated dual elimination by renal and hepatobiliary pathways, as well as slow hydrolysis by plasma cholinesterase. The present
Autor:
Hassan H. Ali, P. B. Embree, S. J. Basta, J. N. Weakly, Robert G. Stout, L. H. Bottros, John J. Savarese
Publikováno v:
British Journal of Anaesthesia. 61:541-546
Mivacurium chloride (BW B1090U) is a new, short-acting non-depolarizing neuromuscular blocking agent. It is a synthetic bis-benzylisoquinolinium diester, which is hydrolysed rapidly by plasma cholinesterase. This study compares mivacurium, atracurium
Autor:
R P, Scott, S J, Basta
Publikováno v:
Comprehensive therapy. 11(3)
Autor:
P. B. Embree, Hassan H. Ali, R. P. F. Scott, N. Sunder, David C. Hoaglin, John J. Savarese, S. J. Basta
Publikováno v:
British journal of anaesthesia. 58(8)
The safety and efficacy of atracurium 0.8 mg kg-1 was determined in healthy patients with particular attention to the speed of onset of blockade, and to changes in haemodynamic variables. Atracurium 0.8 mg kg-1 had a shorter onset time than atracuriu
Publikováno v:
Klinische Wochenschrift. 60(17)
Several experimental and clinical studies have suggested that histamine is released following the administration of neuromuscular blocking agents, and that the histamine release is an important aspect in the hemodynamic response to the drug. We have
Autor:
S J, Basta, H H, Ali, J J, Savarese, N, Sunder, M, Gionfriddo, G, Cloutier, C, Lineberry, A E, Cato
Publikováno v:
Anesthesia and analgesia. 61(9)
Atracurium, a new non-depolarizing neuromuscular blocking agent, was studied in 70 patients anesthetized with fentanyl, thiopental, and nitrous oxide-oxygen. The dose found to produce 95% twitch inhibition (ED95) was 0.2 mg/kg. The onset time from in